Arcus Biosciences, Inc. (RCUS)
NYSE: RCUS · Real-Time Price · USD
25.45
+0.19 (0.75%)
At close: Dec 5, 2025, 4:00 PM EST
25.97
+0.52 (2.04%)
After-hours: Dec 5, 2025, 7:54 PM EST
Arcus Biosciences Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Net Income | -341 | -283 | -307 | -267 | 53 | -123 | |
| Depreciation & Amortization | 10 | 10 | 8 | 6 | 4 | 3 | |
| Asset Writedown & Restructuring Costs | - | 20 | - | - | - | - | |
| Loss (Gain) From Sale of Investments | -16 | -25 | -19 | - | 5 | - | |
| Stock-Based Compensation | 62 | 76 | 73 | 65 | 55 | 22 | |
| Other Operating Activities | 10 | 10 | 10 | 11 | 3 | 1 | |
| Change in Accounts Receivable | 5 | 28 | 15 | 704 | -17 | -1 | |
| Change in Accounts Payable | 29 | 3 | -1 | 8 | -5 | 9 | |
| Change in Unearned Revenue | -256 | -56 | -68 | -112 | -368 | 188 | |
| Change in Other Net Operating Assets | 35 | 47 | -17 | 23 | 14 | 12 | |
| Operating Cash Flow | -462 | -170 | -306 | 438 | -256 | 111 | |
| Capital Expenditures | -2 | -6 | -24 | -6 | -26 | -3 | |
| Investment in Securities | 301 | -78 | 218 | -404 | 22 | -431 | |
| Other Investing Activities | - | - | - | -3 | - | - | |
| Investing Cash Flow | 299 | -84 | 194 | -413 | -4 | -434 | |
| Long-Term Debt Issued | - | 47 | - | - | - | - | |
| Net Debt Issued (Repaid) | 49 | 47 | - | - | - | - | |
| Issuance of Common Stock | 156 | 237 | 33 | 23 | 232 | 439 | |
| Repurchase of Common Stock | -5 | -7 | - | - | - | - | |
| Other Financing Activities | - | - | - | 10 | 5 | - | |
| Financing Cash Flow | 200 | 277 | 33 | 33 | 237 | 439 | |
| Net Cash Flow | 37 | 23 | -79 | 58 | -23 | 116 | |
| Free Cash Flow | -464 | -176 | -330 | 432 | -282 | 108 | |
| Free Cash Flow Margin | -193.33% | -68.22% | -282.05% | 385.71% | -73.63% | 138.46% | |
| Free Cash Flow Per Share | -4.61 | -1.95 | -4.46 | 6.00 | -3.81 | 1.97 | |
| Cash Interest Paid | 1 | 1 | - | - | - | - | |
| Cash Income Tax Paid | - | - | 5 | 3 | - | - | |
| Levered Free Cash Flow | -139.38 | -41.25 | -187.75 | 617.75 | -644.75 | 40.73 | |
| Unlevered Free Cash Flow | -134.38 | -38.75 | -186.5 | 619 | -644.75 | 40.73 | |
| Change in Working Capital | -187 | 22 | -71 | 623 | -376 | 208 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.